| Value | ₹1.47 Cr |
|---|
BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹39.60
- Market cap
- ₹68.52 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 7.6×Sector 46.1×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its shareholding pattern under Regulation 31(1)(c). The filing reports promoter, public and category-wise holdings without any transaction.
Shelter Pharma Preferential Issue
Shelter Pharma Ltd has allotted 4,65,000 equity shares via a preferential issue at ₹42.25 per share. This transaction resulted in a total capital infusion of ₹1.96 Crore.
- Value
- ₹1.96 Cr
Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Shelter Pharma Management Change
Shelter Pharma Limited has regularized Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director for a five-year term, following approval by shareholders at the 19th AGM.
Shelter Pharma Annual General Meeting
Shelter Pharma Limited conducted its 19th Annual General Meeting on September 29, 2026. Key agenda items included adopting financial statements and ratifying material related party transactions.
Shelter Pharma Bags ₹0.1 Cr Order from Berlin International Company
Shelter Pharma received a ₹0.10 Cr export order from Berlin International Company for D3 CURE nutraceuticals. The order broadens its global nutraceutical customer base.
- Value
- ₹0.10 Cr
- From
- Berlin International Company
- Execution
- mutually agreed timelines as per purchase order schedule
Other convertible warrants announcements
All →South West Pinnacle Exploration Convertible Warrants
South West Pinnacle obtained NSE and BSE trading approval for 28,21,411 warrant-conversion shares, listed from 29 October 2026. Allottees include promoters Vikas and Piyush Jain.
Manaksia Coated Metals & Industries Convertible Warrants
Manaksia's monitoring report shows 20 lakh preferential warrants forfeited for unpaid balance, cutting the issue by Rs 9.75 crore. Objects are unfunded for the reduced amount.
- Value
- ₹9.75 Cr
Unifinz Capital India Convertible Warrants
Unifinz's EGM corrigendum seeks approval for up to 98.01 lakh warrants at ₹102 each, worth ₹99.97 Crore. Vikas Goyal's 11.33 lakh warrants are reallocated to Atika Goyal.
- Value
- ₹99.97 Cr
Avalon Technologies Convertible Warrants
Avalon Technologies issued an EGM notice for 21-Nov-2026 to approve convertible warrants via private placement and a related AoA alteration. No monetary value is disclosed in the notice.
Abhinav Leasing & Finance Convertible Warrants
Abhinav Leasing received BSE in-principle approval to issue 6 crore convertible warrants to non-promoters at ₹164 each, raising ₹984 Crore on preferential basis.
- Value
- ₹984.0 Cr
Taylormade Renewables Convertible Warrants
Taylormade Renewables called an EGM on November 18, 2026 to approve issuing up to 14,00,000 warrants to promoters at ₹71.30 each. The issue aggregates about ₹9.98 Crore.
- Value
- ₹9.98 Cr